“…Recently monocyclic or bicyclic iminosugar-based scaffolds from the corresponding chiral cyclic nitrones have been developed and reported in our previous studies, [21,22] and we have used them to build diverse libraries with three diversity elements (core, configuration, and substituent) based on Natural product-inspired combinatorial chemistry (NPICC). [23,24] For example, we have successfully applied this strategy to discover novel protein stabilizers of lysosomal α-galactosidase for the potential treatment of Fabry disease [25,26] and inhibitors against human Golgi α-mannosidase II as potential cancer therapy. [27] To the best of our knowledge, however, the use of this approach to prepare diverse scaffolds and molecular libraries to increase molecular complexity in chemical space for developing α-l-Rha-ase inhibitors has yet to be explored.…”